Literature DB >> 6145789

Comparative effects of selected phenothiazine tranquilizers and antihistaminics on bacterial cells and possible interactions with antibiotics.

A M Shibl, Y Hammouda, I Al-Sowaygh.   

Abstract

Evaluation of the antibacterial effect of phenothiazine antihistaminics (trimeprazine, promethazine, and fonazine) and phenothiazine tranquilizers (promazine, chlorpromazine, triflupromazine, and propiomazine) on Staphylococcus aureus showed that tranquilizers were more active [minimum inhibitory concentration (MIC) 0.5-1.6 micrograms/mL] than antihistaminics (MIC greater than 1.6 micrograms/mL). The antibacterial activity was found to correlate with both the rate of adsorption of these drugs on the bacterial cells and the surface tension of their solutions. Phenothiazine tranquilizers caused rapid and extensive leakage of potassium ions from bacterial cells, while phenothiazine antihistaminics produced relatively slower leakage of these ions. A study of the effect of the phenothiazines on the antibacterial activity of some antibiotics showed that all phenothiazines produced a synergistic effect with erythromycin and an antagonistic effect with tobramycin. Variable effects were observed with chloramphenicol, and no effect was observed with penicillin. Results were explained on the basis of structural characteristics of the phenothiazines.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145789     DOI: 10.1002/jps.2600730638

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

Review 1.  Antimicrobial Properties on Non-Antibiotic Drugs in the Era of Increased Bacterial Resistance.

Authors:  Maria Lagadinou; Maria Octavia Onisor; Athanasios Rigas; Daniel-Vasile Musetescu; Despoina Gkentzi; Stelios F Assimakopoulos; George Panos; Markos Marangos
Journal:  Antibiotics (Basel)       Date:  2020-03-02

2.  In vitro antibacterial activity of some antihistaminics belonging to different groups against multi-drug resistant clinical isolates.

Authors:  Moustafa A El-Nakeeb; Hamida M Abou-Shleib; Amal M Khalil; Hoda G Omar; Omar M El-Halfawy
Journal:  Braz J Microbiol       Date:  2011-09-01       Impact factor: 2.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.